JS_TechTrading

VRTX: opened a new 10% position

Long
NASDAQ:VRTX   Vertex Pharmaceuticals Incorporated
We have added a new position and here is a link to the updated portfolio:

www.tradingview.com/...atchlists/128292848/

VRTX had a positive earnings surprise on Nov 6th which pushed the price up to new highs. These new highs have been followed by a natural pullback which occured under low trading volume.

The new position has been added as the price broke through yesterdays high - a classical low risk pullback entry.

VRTX shows an exceptional RS according to IBD criteria which makes this trade a high momentum play.

General Selection Criteria:
Introducing our cutting-edge trading strategy, a synergy of Cathy Wood's keen fundamental analysis and Mark Minervini's acclaimed trend template criteria.

Imagine having the foresight to identify high-potential technology stocks that are not just promising on paper but are actively demonstrating robust performance in the market. That's the core of our approach. We meticulously select stocks that Cathy Wood's methodology identifies as leaders in technological innovation, ensuring that each company has a solid foundation for growth. But we don't stop there.

We apply Mark Minervini's trend template to verify that these stocks are not only fundamentally sound but are also in a confirmed stage 2 uptrend. This dual-layered strategy ensures that you're investing in companies that are both revolutionizing their industries and are currently capturing the market's momentum.

With our trading strategy, you're not just betting on potential; you're investing in technology stocks that are set to soar, backed by the analytical prowess of two of the most respected names in the trading world. Join us, and be part of a select group of traders who demand the best of both worlds: groundbreaking innovation and proven market trends.

Combing the BEST of two WORLD's: Cathie Wood & Mark Minervini
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.